4//SEC Filing
ALLOS THERAPEUTICS INC 4
Accession 0001097264-07-000020
CIK 0001097264operating
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 8:05 PM ET
Size
6.7 KB
Accession
0001097264-07-000020
Insider Transaction Report
Form 4
Saunders Michael E
VP, Clinical Development
Transactions
- Award
Stock Options (Right to buy)
2007-02-16$7.47/sh+60,000$448,200→ 60,000 totalExercise: $7.47From: 2008-02-16Exp: 2017-02-16→ Common Stock (60,000 underlying)
Holdings
- 7,500
Common Stock
Footnotes (1)
- [F1]Stock options vest according to the following schedule: One fourth (1/4) of the total number of shares subject to this option shall vest 12 months after the vesting commencement date and an additional one-forty-eigths (1/48) of the total number of shares subject to the option become exercisable each one-month-period thereafter, until all such shares are exercisable.
Documents
Issuer
ALLOS THERAPEUTICS INC
CIK 0001097264
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001097264
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 8:05 PM ET
- Size
- 6.7 KB